MCI Radiation Oncology Grand Rounds- Pancreatic Cancer and Radiotherapy: Progress and Future Direction

Miami, FL US
August 9, 2019

Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth leading cause of cancer-related death in North America. Most patients present with locally advanced or metastatic disease that precludes curative resection.  

During this conference Dr. Tuli will discuss the emerging treatment strategies in pancreatic cancer, including the role of immunotherapy.  

Target Audience

Radiation Oncologists, Medical Oncologists, Oncology Surgeons and Radiologists

NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.

Learning Objectives

  • Describe the genomic complexity and molecular heterogeneity of pancreatic cancer.
  • Identify multimodality treatment strategies for localized resectable, borderline and unresectable pancreatic cancer.
  • Implement emerging treatment strategies in pancreatic cancer, including the role of immunotherapy.  
 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Respiratory Therapy
  • 1.00 General certificate of attendance
Course opens: 
07/06/2019
Course expires: 
08/30/2019
Event starts: 
08/09/2019 - 12:00pm
Event ends: 
08/09/2019 - 1:00pm
Rating: 
0
Miami Cancer Institute
8900 N. Kendall Dr
Radiation Oncology Conference Room 1 N 612
Miami, FL 33176
United States

Richard Tuli, M.D., Ph.D. 
Associate Attending
Director of Development Therapeutics
Radiation Oncology
Memorial Sloan Kettering Cancer Center

Richard Tuli, M.D. , Ph.D.,  indicated that he is a consultant with AstraZeneca.  He has received grant/research support from Abbvie and Phase One.  He will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
 

Michael D. Chuong, M.D.
Radiation Oncologist
Baptist Health Quality Network
Baptist and South Miami Hospitals 
Miami, Florida

Dr. Chuong has indicated he has received grant/research support from AstraZeneca and ViewRay. He is on the speakers' bureau for Viewray, Accuray and Sirtex and his discussion will not include mention of investigational or off-label usage.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose. 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1 credit hour, CE Broker Course #20-621028, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity has also been approved for 1 credit hour for Nurses and Nurse Practitioners. Baptist Health South Florida CE Broker Provider #50-182.
 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Nursing
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Respiratory Therapy
  • 1.00 General certificate of attendance

Accreditation Period

Course opens: 
07/06/2019
Course expires: 
08/30/2019
Please login or register to take this course.

NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support